Validation of Diffusion Kurtosis Imaging as an Early-Stage
Biomarker of Parkinson’s Disease in Animal Models

C 2022

Validation of Diffusion Kurtosis Imaging as an Early-Stage Biomarker of Parkinson’s Disease in Animal Models

KHAIRNAR, Amit Suresh, Eva DRAŽANOVÁ, Nikoletta SZABÓ and Jana RUDÁ

Basic information

Original name

Validation of Diffusion Kurtosis Imaging as an Early-Stage Biomarker of Parkinson’s Disease in Animal Models

Name in Czech

Validace zobrazování kurzózy difúze jako časného biomarkeru Parkinsonovy nemoci v animálních modelech

Authors

KHAIRNAR, Amit Suresh (356 India), Eva DRAŽANOVÁ (203 Czech Republic, belonging to the institution), Nikoletta SZABÓ (348 Hungary) and Jana RUDÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

New York, Neurodegenerative Diseases Biomarkers, p. 429-455, 27 pp. Neuromethods, vol 173, 2022

Publisher

Humana

Other information

Language

English

Type of outcome

Chapter(s) of a specialized book

Field of Study

30103 Neurosciences

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

Publication form

electronic version available online

References:

URL

RIV identification code

RIV/00216224:14110/22:00125015

Organization unit

Faculty of Medicine

ISBN

978-1-0716-1711-3

DOI

http://dx.doi.org/10.1007/978-1-0716-1712-0_18

UT WoS

000868553200020

Keywords in English

Diffusion kurtosis imaging; Diffusion tensor imaging; Magnetic resonance imaging; Methamphetamine; Microstructural changes; Neurodegeneration; α-Synuclein; TNWT-61 Mice

Abstract

V originále

The main aim of this chapter is to provide detailed information of how to perform the DKI imaging acquisition and analysis in the mouse brain, which can be, to some extent translated to humans.

Links

EF16_013/0001775, research and development project

Name: Modernizace a podpora výzkumných aktivit národní infrastruktury pro biologické a medicínské zobrazování Czech-BioImaging

LM2015062, research and development project

Name: Národní infrastruktura pro biologické a medicínské zobrazování

Investor: Ministry of Education, Youth and Sports of the CR

MUNI/A/1249/2020, interní kód MU

Name: Základní výzkum v oblasti farmakokinetiky, neurobiologie závislostí a aplikovaný výzkum v oblasti personalizované farmakoterapie v onkologii (Acronym: SV_Farmakologie2021)

Investor: Masaryk University

Citovat

KHAIRNAR, Amit Suresh, Eva DRAŽANOVÁ, Nikoletta SZABÓ and Jana RUDÁ. Validation of Diffusion Kurtosis Imaging as an Early-Stage Biomarker of Parkinson’s Disease in Animal Models. Online. In Peplow P.V., Martinez B., Gennarelli T.A. Neurodegenerative Diseases Biomarkers. New York: Humana, 2022, p. 429-455. Neuromethods, vol 173. ISBN 978-1-0716-1711-3. Available from: https://dx.doi.org/10.1007/978-1-0716-1712-0_18.

@inbook{1798401,
   author = {Khairnar, Amit Suresh and Dražanová, Eva and Szabó, Nikoletta and Rudá, Jana},
   address = {New York},
   booktitle = {Neurodegenerative Diseases Biomarkers},
   doi = {http://dx.doi.org/10.1007/978-1-0716-1712-0_18},
   editor = {Peplow P.V., Martinez B., Gennarelli T.A.},
   keywords = {Diffusion kurtosis imaging; Diffusion tensor imaging; Magnetic resonance imaging; Methamphetamine; Microstructural changes; Neurodegeneration; α-Synuclein; TNWT-61 Mice},
   howpublished = {elektronická verze "online"},
   language = {eng},
   location = {New York},
   isbn = {978-1-0716-1711-3},
   pages = {429-455},
   publisher = {Humana},
   title = {Validation of Diffusion Kurtosis Imaging as an Early-Stage Biomarker of Parkinson’s Disease in Animal Models},
   url = {https://link.springer.com/protocol/10.1007%2F978-1-0716-1712-0_18},
   year = {2022}
}

TY  - CHAP
ID  - 1798401
AU  - Khairnar, Amit Suresh - Dražanová, Eva - Szabó, Nikoletta - Rudá, Jana
PY  - 2022
TI  - Validation of Diffusion Kurtosis Imaging as an Early-Stage Biomarker of Parkinson’s Disease in Animal Models
VL  - Neuromethods, vol 173
PB  - Humana
CY  - New York
SN  - 9781071617113
KW  - Diffusion kurtosis imaging
KW  - Diffusion tensor imaging
KW  - Magnetic resonance imaging
KW  - Methamphetamine
KW  - Microstructural changes
KW  - Neurodegeneration
KW  - α-Synuclein
KW  - TNWT-61 Mice
UR  - https://link.springer.com/protocol/10.1007%2F978-1-0716-1712-0_18
N2  - The main aim of this chapter is to provide detailed information of how to perform the DKI imaging acquisition and analysis in the mouse brain, which can be, to some extent translated to humans.
ER  -

KHAIRNAR, Amit Suresh, Eva DRAŽANOVÁ, Nikoletta SZABÓ and Jana RUDÁ. Validation of Diffusion Kurtosis Imaging as an Early-Stage Biomarker of Parkinson’s Disease in Animal Models. Online. In Peplow P.V., Martinez B., Gennarelli T.A. \textit{Neurodegenerative Diseases Biomarkers}. New York: Humana, 2022, p.~429-455. Neuromethods, vol 173. ISBN~978-1-0716-1711-3. Available from: https://dx.doi.org/10.1007/978-1-0716-1712-0\_{}18.

Přehled o publikaci